Chronic hepatitis B infection is common in the United States, yet only a minority of eligible people are screened, vaccinated, and receive treatment. Th e Ryan White HIV/AIDS program has been a key tool for ensuring that socioeconomically disadvantaged HIV-infected patients have access to care. Many of the same disease and patient attributes that make the Ryan White program necessary and eff ective for HIV exist in chronic hepatitis B. Th us, we believe that the current Ryan White program should be expanded to care for people with hepatitis B under similar regulations. Considering recent changes proposed to the health insurance marketplace, policymakers should strongly consider inclusion of chronic hepatitis B in the safety- net Ryan White Program.
|Original language||English (US)|
|Number of pages||7|
|Journal||Journal of health care for the poor and underserved|
|State||Published - Aug 2020|
Bibliographical noteFunding Information:
Dr. Bahr is funded by the National Institute of Neurological Diseases and Stroke of the National Institutes of Health, K23 NS110470.
- Chronic hepatitis B
- Linkage to care
- Ryan White Program